Vimarsana
Biggest News Aggregation in the World

Page 3 - Paper Presented News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Paper Presented. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Paper Presented Today - Breaking & Trending Today

Understanding ALCHEMIST Results, with Patrick Rossignol, MD, PhD - Vimarsana News

Understanding ALCHEMIST Results, with Patrick Rossignol, MD, PhD

Patrick Rossignol, MD, PhD, provides additional perspective on the results of the ALCHEMIST trial from Kidney Week 2023.

Early RUBY-3 Data Shows Promise for Povetacicept in Glomerulonephritis - Vimarsana News

Early RUBY-3 Data Shows Promise for Povetacicept in Glomerulonephritis

Preliminary data from the open-label RUBY-3 trial were presented at the American Society of Nephrology Kidney Week 2023.

More than 50% of CKD Patients with Anemia Receive No Treatment, Study Finds - Vimarsana News

More than 50% of CKD Patients with Anemia Receive No Treatment, Study Finds

Analysis of nearly 15k patients with non-dialysis-dependent CKD and anemia provides insight into contemporary trends in management.

Phase 2b Data, Phase 3 Trial Design Provide New Insight into Atacicept in IgAN - Vimarsana News

Phase 2b Data, Phase 3 Trial Design Provide New Insight into Atacicept in IgAN

Data from multiple presentations at ASN Kidney Week 2023 offer insight into the effects of atacicept in patients with IgA nephropathy as well as the design of the phase 3 trial, which is currently enrolling.

Budesonide Reduces eGFR Decline, Effect Could Prevent Clinical Events in IgA Nephropathy - Vimarsana News

Budesonide Reduces eGFR Decline, Effect Could Prevent Clinical Events in IgA Nephropathy

Data for a pair of studies presented at Kidney Week 2023 provide an overview of the effects of eGFR and how this might translate to potential long-term benefit in patients IgA nephropathy.